Here's how to make phase 4 clinical trials (either survey quality of life trials or standard-of-care trials). more lucrative for clinical research sites.
An electronic investigator site file (eISF) technology platform helps life sciences organizations efficiently operate in a disaggregated industry.
There are secure collaboration solutions that can automate drug development processes and help achieve ROI — while protecting intellectual property.
Given the rebounding deal market, it may come as no surprise that there is an uptick in life sciences M&A in the United States.
SUSAR reporting can be faster, more resource-effective and ensure greater privacy for patients. Implementing an automated SUSAR distribution and reporting solution offers numerous benefits to all parties involved in a clinical trial - improving patient safety and regulatory compliance, while reducing the manual efforts involved.